Trobix Bio is a company that develops and commercializes antibacterial products.
Trobix Bio has raised €2.6M across 1 funding round, most recently a Series A round in Jul 2020. Based in Netanya, Israel; founded 2018; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-31 | Series A | €2.6M |
| — |
| View deal → |
